NCT01902498View on ClinicalTrials.gov

Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part B

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

July 31, 2014

Conditions

Postoperative Dysfunction Following Cardiac Surgery

Interventions

DRUG

Aspirin

Aspirin 81mg po daily x 7days or end of hospitalization. First dose administered on post op day 1.

DRUG

Aspirin

Aspirin 325mg po daily x 7days or end of hospitalization. First dose administered on post op day 1.

DRUG

Aspirin

Aspirin 162mg po twice daily x 7days or end of hospitalization. First dose administered on post op day 1.

Trial Locations (1)

L8L2X2

Hamilton General Hospital, Hamilton

All Listed Sponsors

lead

Hamilton Health Sciences Corporation

OTHER

NCT01902498 - Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part B | Biotech Hunter | Biotech Hunter